Andrew Allen
Company: Gritstone Bio
Job title: President & Chief Executive Officer
Seminars:
Chair’s Closing Remarks & End of Conference Day One 5:20 pm
day: Day One
Chair’s Opening Remarks 8:40 am
day: Day One
Clinical Trial Data with a Personalized Neoantigen Cancer Vaccine in Metastatic Colorectal Cancer 12:30 pm
We have developed a heterologous prime-boost personalized neoantigen cancer vaccine using adenoviral prime and self-amp mRNA boost vectors Phase 1 data demonstrated good safety, immunogenicity and early signals of clinical benefit A randomized, controlled phase 2 trial in metastatic colorectal cancer is expected to report preliminary data from a subset of patients in 1 Q24Read more
day: Day One